Reaction

Hepatic Cyst reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,348 reports · 151 co-occurring drugs

As of the last recalculation, Hepatic Cyst appears in 3,348 FAERS reports alongside 151 co-occurring drug terms. The strongest observed disproportionality signal is AMIODARONE HYDROCHLORIDE (PRR 17.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Amiodarone Hydrochloride	32	17.9	18.0
Chlorhexidine Gluconate	22	15.1	15.1
Fulvestrant	76	14.6	14.6
Tolvaptan	32	13.8	13.8
Etonogestrel And Ethinyl Estradiol	47	13.3	13.4
Isoniazid	33	12.8	12.8
Ado-Trastuzumab Emtansine	17	12.6	12.6
Torsemide	60	11.4	11.5
Febuxostat Tablets 40 Mg	18	11.1	11.1
Febuxostat Tablets 80 Mg	18	11.1	11.1
Ribociclib	55	11.0	11.0
Quinine	15	10.9	10.9
Goserelin	23	10.7	10.7
Valsartan Oral	86	10.1	10.1
Alendronate Sodium	144	9.2	9.2
Polatuzumab Vedotin	14	9.0	9.0
Letrozole	85	8.8	8.8
Anastrozole	49	8.4	8.4
Isosorbide Dinitrate	26	8.3	8.3
Anastrozole Tablets	28	8.2	8.2
Melphalan Hydrochloride	32	8.0	8.0
Melphalan	29	8.0	8.0
Crizotinib	16	7.9	7.9
Lactulose	47	7.7	7.7
Olmesartan Medoxomil	44	7.7	7.7
Valsartan And Hydrochlorothiazide	16	7.4	7.4
Febuxostat	19	7.1	7.1
Octreotide Acetate	34	7.0	7.0
Magnesium Hydroxide	15	6.9	7.0
Metoprolol Succinate Er Tablets	68	6.9	6.9
Valsartan	110	6.7	6.7
Cephalexin	23	6.6	6.7
Metronidazole	66	6.5	6.5
Zidovudine	14	6.5	6.5
Captopril	10	6.5	6.5
Metoprolol Succinate	88	6.5	6.5
Losartan Potassium And Hydrochlorothiazide	12	6.4	6.4
Rabeprazole Sodium	28	6.4	6.4
Letrozole Tablets	49	6.4	6.4
Lanreotide Acetate	8	6.4	6.4
Tolterodine Tartrate	9	6.2	6.3
Gefitinib	9	6.2	6.2
Vitamin E	31	6.2	6.2
Mometasone Furoate	40	6.0	6.0
Exemestane	20	5.8	5.8
Diltiazem Hydrochloride	32	5.8	5.8
Amoxicillin And Clavulanate Potassium	25	5.8	5.8
Sodium Chloride Tablet	66	5.7	5.7
Sodium Chloride Tablets	66	5.7	5.7
Docusate Sodium - Sennosides	29	5.6	5.6
Lapatinib	14	5.6	5.6
Pantoprazole Sodium In 0.9% Sodium Chloride	55	5.6	5.6
Pantoprazole Sodium Injection	55	5.6	5.6
Metronidazole Topical	42	5.5	5.5
Sodium Chloride	69	5.5	5.5
Piperacillin Sodium And Tazobactam Sodium	17	5.4	5.4
Amlodipine Besylate And Benazepril Hydrochloride	8	5.4	5.4
Esomeprazole	53	5.4	5.4
Ezetimibe And Simvastatin	13	5.3	5.3
Clindamycin Phosphate	28	5.2	5.3
Sitagliptin And Metformin Hydrochloride	18	5.2	5.2
Ciprofloxacin Hydrochloride And Hydrocortisone	17	5.1	5.1
Diclofenac Sodium 1%	29	5.1	5.1
Diclofenac Sodium Topical	29	5.1	5.1
Diclofenac Sodium Topical Gel, 1%	29	5.1	5.1
Timolol Maleate	8	5.0	5.0
Piperacillin Sodium,Tazobactam Sodium	21	4.9	4.9
Piperacillin And Tazobactam	10	4.9	4.9
Trastuzumab	53	4.9	4.9
Clopidogrel Bisulfate	78	4.8	4.8
Capecitabine	69	4.8	4.8
Methimazole	6	4.8	4.8
Dorzolamide Hydrochloride And Timolol Maleate	6	4.7	4.7
Sitagliptin	54	4.7	4.7
Loratadine And Pseudoephedrine Sulfate	6	4.7	4.7
Raloxifene Hydrochloride	11	4.7	4.7
Abemaciclib	15	4.7	4.7
Folic Acid	179	4.7	4.7
Cholestyramine	9	4.6	4.6
Conjugated Estrogens	43	4.6	4.6
Simvastatin	177	4.6	4.6
Estrogens, Conjugated	43	4.5	4.6
Enoxaparin Sodium	41	4.5	4.5
Amlodipine Besylate	101	4.4	4.4
Celecoxib	89	4.3	4.3
Amoxicillin	52	4.3	4.3
Losartan Potassium	51	4.1	4.1
Bendamustine Hcl	10	4.0	4.0
Panitumumab	10	4.0	4.0
Erythropoietin	13	3.9	3.9
Prochlorperazine	17	3.8	3.8
Doxorubicin Hydrochloride	20	3.8	3.8
Filgrastim	23	3.8	3.8
Regorafenib	7	3.8	3.8
Thalidomide	22	3.7	3.7
Conjugated Estrogens And Medroxyprogesterone Acetate	14	3.7	3.7
Pazopanib Hydrochloride	16	3.7	3.7
Bicalutamide	9	3.7	3.7
Dexamethasone Sodium Phosphate	6	3.7	3.7
Pertuzumab	16	3.7	3.7
Zoledronic Acid	23	3.6	3.6
Acetaminophen And Codeine	7	3.6	3.6
Lamivudine Oral	14	3.5	3.5
Efavirenz	6	3.3	3.4
Cladribine	5	3.2	3.2
Carboplatin	64	3.2	3.2
Mepolizumab	25	3.1	3.1
Etoposide	36	3.1	3.1
Atezolizumab	19	3.1	3.1
Gemcitabine	19	3.0	3.0
Imatinib Mesylate	13	2.9	2.9
Ifosfamide	10	2.9	2.9
Bevacizumab	57	2.9	2.9
Calcium, Magnesium, Potassium, And Sodium Oxybates	4	2.9	2.9
Docetaxel Anhydrous	31	2.9	2.9
Docetaxel	31	2.9	2.9
Methadone Hydrochloride	5	2.9	2.9
Brinzolamide	4	2.9	2.9
Siponimod	4	2.8	2.8
Darbepoetin Alfa	24	2.8	2.8
Denosumab	89	2.8	2.8
Olaparib	9	2.7	2.7
Entecavir	5	2.7	2.7
Acetaminophen, Aspirin (Nsaid) And Caffeine	7	2.6	2.6
Palbociclib	39	2.6	2.6
Axitinib	8	2.6	2.6
Niraparib	9	2.5	2.5
Oxaliplatin	29	2.4	2.4
Pemetrexed	8	2.3	2.3
Paclitaxel	36	2.3	2.3
Interferon Beta-1B	7	2.3	2.3
Methoxy Polyethylene Glycol-Epoetin Beta	4	2.3	2.3
Iohexol	3	2.3	2.3
Gemcitabine Hydrochloride	19	2.2	2.2
Interferon Beta-1A	68	2.2	2.2
Exenatide	18	2.1	2.1
Dabigatran Etexilate	26	2.1	2.1
Ustekinumab	34	2.1	2.1
Acetaminophen, Aspirin, And Caffeine	7	2.1	2.1
Orlistat	8	1.9	1.9
Suvorexant	4	1.9	1.9
Peginterferon Beta-1A	4	1.9	1.9
Fam-Trastuzumab Deruxtecan-Nxki	3	1.9	1.9
Dabigatran Etexilate Mesylate	21	1.8	1.8
Trifluridine And Tipiracil	3	1.7	1.7
Benralizumab	5	1.6	1.6
Drospirenone And Ethinyl Estradiol	11	1.5	1.5
Dimethyl Fumarate	28	1.4	1.4
Erenumab-Aooe	10	1.1	1.1
Minoxidil Foam 5% (Womens)	5	0.9	0.9
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	4	0.8	0.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.